Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate

The Plasmodium falciparum circumsporozoite protein (CSP) is critical for sporozoite function and invasion of hepatocytes. Given its critical nature, a phase III human CSP malaria vaccine trial is ongoing. The CSP is composed of three regions as follows: an N terminus that binds heparin sulfate proteoglycans, a four amino acid repeat region (NANP), and a C terminus that contains a thrombospondin-like type I repeat (TSR) domain. Despite the importance of CSP, little is known about its structure. Therefore, recombinant forms of CSP were produced by expression in both Escherichia coli (Ec) and then refolded (EcCSP) or in the methylotrophic yeast Pichia pastoris (PpCSP) for structural analyses. To analyze the TSR domain of recombinant CSP, conformation-dependent monoclonal antibodies that recognized unfixed P. falciparum sporozoites and inhibited sporozoite invasion of HepG2 cells in vitro were identified. These monoclonal antibodies recognized all recombinant CSPs, indicating the recombinant CSPs contain a properly folded TSR domain structure. Characterization of both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation demonstrated that both forms of CSP appeared as highly extended proteins (Rh 4.2 and 4.58 nm, respectively). Furthermore, high resolution atomic force microscopy revealed flexible, rod-like structures with a ribbon-like appearance. Using this information, we modeled the NANP repeat and TSR domain of CSP. Consistent with the biochemical and biophysical results, the repeat region formed a rod-like structure about 21–25 nm in length and 1.5 nm in width. Thus native CSP appears as a glycosylphosphatidylinositol-anchored, flexible rod-like protein on the sporozoite surface. The Plasmodium falciparum circumsporozoite protein (CSP) is critical for sporozoite function and invasion of hepatocytes. Given its critical nature, a phase III human CSP malaria vaccine trial is ongoing. The CSP is composed of three regions as follows: an N terminus that binds heparin sulfate proteoglycans, a four amino acid repeat region (NANP), and a C terminus that contains a thrombospondin-like type I repeat (TSR) domain. Despite the importance of CSP, little is known about its structure. Therefore, recombinant forms of CSP were produced by expression in both Escherichia coli (Ec) and then refolded (EcCSP) or in the methylotrophic yeast Pichia pastoris (PpCSP) for structural analyses. To analyze the TSR domain of recombinant CSP, conformation-dependent monoclonal antibodies that recognized unfixed P. falciparum sporozoites and inhibited sporozoite invasion of HepG2 cells in vitro were identified. These monoclonal antibodies recognized all recombinant CSPs, indicating the recombinant CSPs contain a properly folded TSR domain structure. Characterization of both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation demonstrated that both forms of CSP appeared as highly extended proteins (Rh 4.2 and 4.58 nm, respectively). Furthermore, high resolution atomic force microscopy revealed flexible, rod-like structures with a ribbon-like appearance. Using this information, we modeled the NANP repeat and TSR domain of CSP. Consistent with the biochemical and biophysical results, the repeat region formed a rod-like structure about 21–25 nm in length and 1.5 nm in width. Thus native CSP appears as a glycosylphosphatidylinositol-anchored, flexible rod-like protein on the sporozoite surface. Malaria caused by Plasmodium falciparum is a serious global health issue, resulting in an estimated 1.5 million deaths annually, primarily among infants and young children. Ongoing multifaceted global intervention strategies to control malaria include drug treatment, insecticide usage, bed-net use, and vaccine development. However, parasite and mosquito control measures have met with limited success resulting from an increased drug and insecticide resistance within the Plasmodia and mosquito populations, respectively. Vaccine development represents an encouraging approach given that previous animal and human studies using irradiated sporozoites demonstrated the feasibility of producing an efficacious vaccine (1Clyde D.F. Most H. McCarthy V.C. Vanderberg J.P. Am. J. Med. Sci. 1973; 266: 169-177Crossref PubMed Scopus (427) Google Scholar, 2Nussenzweig R.S. Vanderberg J. Most H. Orton C. Nature. 1967; 216: 160-162Crossref PubMed Scopus (660) Google Scholar, 3Nussenzweig R.S. Vanderberg J.P. Most H. Orton C. Nature. 1969; 222: 488-489Crossref PubMed Scopus (114) Google Scholar). Although the exact immunologic correlates of protection remain elusive, an abundance of evidence indicates that protection against liver stage parasites is complex, involving multiple immune mechanisms (4Franke E.D. Sette A. Sacci Jr., J. Southwood S. Corradin G. Hoffman S.L. Infect. Immun. 2000; 68: 3403-3411Crossref PubMed Scopus (35) Google Scholar, 5Hollingdale M.R. Zavala F. Nussenzweig R.S. Nussenzweig V. J. Immunol. 1982; 128: 1929-1930PubMed Google Scholar, 6Rodrigues E.G. Claassen J. Lee S. Wilson J.M. Nussenzweig R.S. Tsuji M. Parasite Immunol. 2000; 22: 157-160Crossref PubMed Scopus (36) Google Scholar, 7Weiss W.R. Mellouk S. Houghten R.A. Sedegah M. Kumar S. Good M.F. Berzofsky J.A. Miller L.H. Hoffman S.L. J. Exp. Med. 1990; 171: 763-773Crossref PubMed Scopus (182) Google Scholar, 8Weiss W.R. Sedegah M. Beaudoin R.L. Miller L.H. Good M.F. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 573-576Crossref PubMed Scopus (443) Google Scholar, 9Weiss W.R. Sedegah M. Berzofsky J.A. Hoffman S.L. J. Immunol. 1993; 151: 2690-2698PubMed Google Scholar, 10Kumar S. Miller L.H. Quakyi I.A. Keister D.B. Houghten R.A. Maloy W.L. Moss B. Berzofsky J.A. Good M.F. Nature. 1988; 334: 258-260Crossref PubMed Scopus (165) Google Scholar, 11Schofield L. Villaquiran J. Ferreira A. Schellekens H. Nussenzweig R. Nussenzweig V. Nature. 1987; 330: 664-666Crossref PubMed Scopus (615) Google Scholar). To date, the majority of the pre-erythrocytic stage vaccine development has focused on the circumsporozoite protein (CSP), 2The abbreviations used are: CSPcircumsporozoite proteinTSRthrombospondin-like type I repeatmAbmonoclonal antibodyISIinhibition of sporozoite invasionECMEagle's essential minimum complete mediaDTTdithiothreitolBisTris2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diolPBSphosphate-buffered salineSEC-MALS-QELS-HPLCsize exclusion chromatography-multiangle light scattering-quasi-elastic light scatter detection; high pressure liquid chromatographyqRTquantitative real timerrecombinantAFMatomic force microscopyEcCSPE. coli CSPPpCSPP. pastoris CSPESI-MSelectrospray ionization-mass spectrometry-MLmechanical microfluidization lysis-CLchemical detergent lysis. the predominant surface antigen on sporozoites. CSP can be segmented into three regions as follows: the N-terminal region containing region I; the central repeat region; and the C-terminal region containing the thrombospondin-like type I repeat (TSR). CSP vaccine development focused on the central repeat region that contains the D.F. G. M. J. S. 1987; PubMed Scopus Google Scholar). However, vaccine to both the central repeat region containing the and the C terminus containing the TSR and J.M. Nussenzweig R.S. B. C. S. R. J. Infect. 2000; PubMed Scopus Google Scholar, J.A. M. P. P. M. J. Med. PubMed Scopus Google Scholar). the and malaria is composed of a of the central repeat and the C-terminal regions to the surface antigen P. J. A. A. M. J. S. J. P. P. A. S. B. W.R. J. L. J. Med. PubMed Scopus Google Scholar). However, studies have the importance of the N-terminal region R. J. PubMed Scopus Google Scholar, S. M. P. R. Corradin G. PubMed Scopus Google Scholar, R. R. P. Kumar S. J. PubMed Scopus Google Scholar, Sacci P. J. PubMed Scopus Google Scholar). Sacci P. J. PubMed Scopus Google demonstrated the of the N-terminal region in liver with and R. J. PubMed Scopus Google an within the N-terminal region that with liver cells heparin sulfate R. R. P. Kumar S. J. PubMed Scopus Google Scholar). this to be the resulting antibodies were to be in a sporozoite invasion R. R. P. Kumar S. J. PubMed Scopus Google Scholar). to the N-terminal region and were recognized by from in regions S. M. P. R. Corradin G. PubMed Scopus Google Scholar). circumsporozoite protein thrombospondin-like type I repeat monoclonal of sporozoite invasion essential minimum complete exclusion chromatography-multiangle light scattering-quasi-elastic light scatter detection; high pressure liquid real recombinant atomic force microscopy coli CSP P. pastoris CSP ionization-mass microfluidization detergent lysis. To the structure of CSP and to recombinant protein for human we and recombinant CSP. expression Escherichia coli and Pichia to feasibility to CSP. To the of the we a of monoclonal antibodies that were to used to the of the and The have the of CSP as a flexible, rod-like To antibodies CSP, we a CSP by The to CSP amino to into the expression using the and The resulting a The of CSP to produced as R.L. PubMed Scopus Google and using a by exclusion to to a of were with a with an N-terminal amino acid were by against sporozoite and microscopy of sporozoites. to be were and using the the To or the the were using an in vitro to to sporozoite invasion of HepG2 of the invasion of HepG2 cells M.R. P. Am. J. Med. PubMed Scopus Google by P. falciparum sporozoites in the or of using to the invasion of the HepG2 The for the of a with in for to the HepG2 HepG2 cells were in essential minimum complete essential minimum containing and for HepG2 cells were and in to a of of of the HepG2 to and P. falciparum sporozoites were in were in a for and in were then in containing and mosquito by the from the and the from the The were in all were the were and by a The sporozoites from the were and in to a of to be in to the The (CSP) falciparum sporozoite by with used as a to a of of the or control with of the sporozoite and for and then of to and for the invasion with and To a for the sporozoites were in to to HepG2 and an HepG2 cells were and to an sporozoites were by the cells for The or used for and from using the and in a using with an used in to to and then to using the high of were used in a the for for for The resulting used or The and were used to parasite To the and were with to a of in a The then in a to parasite using the as follows: stage for stage for and for were were with the from containing known of sporozoites. The by the of sporozoites with the of sporozoites to sporozoites a and were with a of or with by with a of and the proteins were a for using V. J. R.L. L. C. R. Infect. Immun. PubMed Scopus Google Scholar, Infect. Immun. 2000; 68: PubMed Scopus Google Scholar). were in with of the by the with from the in and with using the as the of recombinant protein on and as using and as S. M. Miller L.H. Proc. Natl. Acad. Sci. U.S.A. PubMed Scopus Google Scholar). by the were with and with J. PubMed Scopus Google Scholar). and were and by with containing The were using and then were by microscopy as S. M. Miller L.H. Proc. Natl. Acad. Sci. U.S.A. PubMed Scopus Google Scholar). using used for were by using a and a of by an were as with a of nm the of all using to the resolution of the as as to were and in this as of the The amino acid of CSP used to a for expression in coli The to amino to of the CSP, into the coli expression of the using the and The resulting the amino acid EcCSP using coli of in a using as S. Miller L.H. Infect. Immun. PubMed Scopus Google Scholar). the nm the to and by to a of for by and The using or lysis. the in of and a three The for to and the and EcCSP then from the using a and using a containing and the in of and for the of to the of of The for to and were with and then in EcCSP and using a EcCSP refolded on a of of a on a with and from the using EcCSP and on a and using a exclusion with the coli expression of CSP, the amino acid of CSP used to a Pichia for expression in the methylotrophic yeast P. pastoris CSP to amino to into the and of the Pichia expression as the The resulting a to with and into P. the of CSP protein produced in as V. J. R.L. L. C. R. Infect. Immun. PubMed Scopus Google Scholar, Jr., R.L. Miller L.H. J. PubMed Scopus Google Scholar). be However, in PpCSP to by on a by and with a exclusion The antigen to in and were using a with the were were to the of the recombinant and were to the using an to the The surface with an of by of in in or in were with of the in or cells and were and then to as the recombinant proteins were in from nm to were a of for The using of for and with a were using and a the on a as protein in to a of protein as and were in and nm, and to the The using of for and with a a to nm, the and as To in were in were the nm in a length using a of nm, a of nm, and a of of on structure in from to structure using the L. PubMed Scopus Google Scholar, L. PubMed Scopus Google Scholar). To the and of EcCSP and exclusion with light scattering and light scatter on an to a light scattering and a light scattering were and as by S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google Scholar). sedimentation velocity were in velocity a of The with of protein a of PpCSP or were to the velocity into as P. J. 2000; PubMed Scopus Google using the domain by The of this is a of the of in the of a this treatment, the sedimentation velocity were to for the of P. J. 2000; PubMed Scopus Google that the is from the and this for the of the to a the of The by and used to the of the PpCSP and the and for the used in the sedimentation and for the to be for were and as by S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google with as of the protein a of both in and using with a of a a type and a or S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google Scholar, R. J. PubMed Scopus Google Scholar). protein by of of of of in on by with of and complete an The then into the by S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google Scholar). were within the and to of and for and structure of the N-terminal domain structure using R.L. PubMed Scopus Google and J. Proc. Natl. Acad. Sci. U.S.A. PubMed Scopus Google Scholar, J. M. A. F. J. Scopus Google Scholar). The repeat region modeled by structures of the The structure of A. A. J.A. Google to the structure of of the C. C. J. J.A. J. Am. Scopus Google to the and The structure of extended by of a to of the this to of the native CSP were into the N terminus of the repeat region to the and were using Jr., R.L. Sci. PubMed Scopus Google Scholar). The TSR domain modeled using the and S. PubMed Scopus Google Scholar). were and for the of the of the by R. J. J. M. R. PubMed Scopus Google J. J. PubMed Scopus Google and S. PubMed Scopus Google to TSR M. R. A. J. J. PubMed Scopus Google using B. A. in Scholar). structure for the repeat region and the TSR domain by C. 22: PubMed Scopus Google and structure and were using J. PubMed Scopus Google and W.L. The Scholar). To the of recombinant CSP in coli (EcCSP) and P. pastoris (PpCSP) a of by against sporozoite to for three of the in and the CSP Nussenzweig R.S. Infect. Immun. PubMed Google Scholar, P. Nussenzweig V. Nussenzweig R.S. J. Exp. Med. PubMed Scopus Google on both and sporozoite as by These the NANP three and with the sporozoite a with the and sporozoite by and To the for the of for to sporozoites by three with a surface in from microscopy using and the recognized CSP on the we to invasion of liver cells by P. falciparum sporozoites the invasion and and of sporozoite invasion of HepG2 cells of of a sporozoite with three and and microscopy of sporozoites. were with the monoclonal and using antibodies with using P. falciparum sporozoites and HepG2 liver in a CSP were used to CSP in coli and P. pastoris expression and as forms of refolded and EcCSP were and on the microfluidization and detergent The and of and as as the by and high is in of the of an N-terminal in and PpCSP with the in a by by using and with all three recombinant and PpCSP and were to by with a protein to the TSR domain in a These three were and and to be The of and PpCSP with the three and by surface To the or of the three and to and of the to the surface of a for The of the the recombinant proteins The of the and for and nm, respectively. for the of the three and and by surface demonstrated the and an and biophysical of the three recombinant proteins using ionization-mass N-terminal and to the and of the Using the from of the by The for the of PpCSP is within of the indicating the biochemical of the protein is with that the is to the of both proteins by N-terminal the N-terminal for and PpCSP to and the for to the for the on and N-terminal a of CSP with N-terminal for of proteins and and biophysical of and N-terminal for and PpCSP the to amino and respectively. contains a of N-terminal The amino acid to the amino acid within the acid from to velocity indicates The N-terminal for and PpCSP the to amino and respectively. contains a of N-terminal The amino acid to the amino acid within the acid indicates in a of PpCSP and EcCSP were to of the for structure for PpCSP using the L. PubMed Scopus Google Scholar, L. PubMed Scopus Google PpCSP composed of and structure. were for both of the three recombinant proteins were for in structure of by a that a in and in a in the structure of PpCSP with increased as by increased in and nm and a from to nm The of the structure by the to or from structure as by a in the of the the were for and The for PpCSP in the nm, little is of a of structure These were with from and of the three recombinant proteins by to and of PpCSP by of the protein in with of the by composed of populations, a and a composed of a of and of the from and have to the of of the three proteins by the of the to the of protein and To the recombinant the of the recombinant proteins were by The of PpCSP 4.2 nm indicating the of PpCSP is highly extended with a protein for S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google Scholar). the of for the to a To the recombinant an approach used to the and sedimentation velocity used to the sedimentation of the PpCSP The of the were by the to the sedimentation of protein in The of in the to for of the a of S. for the of the and of we an of S. The sedimentation with the for the of the into a as in the of The of the is is in with the of Using the and the of we the a of and a of 4.58 on the for CSP, is to the of this protein as a Using this with an estimated of of of the CSP or have length and of and nm, respectively. sedimentation of used for PpCSP is of to the sedimentation and of with the we an of to an of S. The in be given the of for The from the The from the in with the of from the and The for EcCSP is this CSP as a or we length and of and nm, respectively. is that the sedimentation and of PpCSP and with in were with and The from the sedimentation of is in The that be the for CSP. that PpCSP protein is an extended and flexible with a ribbon-like with the about PpCSP protein is in a with the protein the of The of the protein a of and of The protein in all with the extended by the of the as a for a extended the length to to be and to the PpCSP a protein about to the of the is and within the of to the an of the nm for PpCSP as appeared on for EcCSP ribbon-like with rod-like with Therefore, high resolution the of the structures from the as for the repeat region and for of the TSR domain. The structure for the of the repeat the TSR and the N-terminal domain to the EcCSP about and in with the of about and the repeat region were to have little structure. The TSR domain contains and and and and forms an extended structure about nm in length and nm in width. be by a from about to the C terminus The repeat region forms a about nm in length and 1.5 nm in composed of with a of about or repeat of in the of the a to the structure and a to the N terminus of the repeat region multiple vaccine the of a CSP have against from to and against malaria in J. A. J. B. C. M. P. S. M. F. C. W.R. R. J. PubMed Scopus Google Scholar, P. M. J. S. A. A. M. J. B. M. B. W.R. J. PubMed Scopus Google Scholar, M. L. A. W.R. P. L. M. G. A. PubMed Scopus Google Scholar). However, the the N-terminal region of CSP, has to be a critical domain R. J. PubMed Scopus Google Scholar, S. M. P. R. Corradin G. PubMed Scopus Google Scholar, R. R. P. Kumar S. J. PubMed Scopus Google Scholar, Sacci P. J. PubMed Scopus Google Scholar). to and recombinant CSP the N repeat and C with the of a of the structure of CSP. we the and the and biophysical of CSP from expression coli and P. The recombinant from expression were in all of the biochemical and biophysical to the that CSP is a highly rod-like protein on the surface of sporozoites. To the and to that both EcCSP and PpCSP have structural to native CSP, we a of to The S. expression for of recombinant CSP of of expression To of to the TSR domain of CSP, were with a to the TSR domain as by N-terminal The were by against sporozoite microscopy of and a sporozoite invasion to as as to for of recombinant CSP The by of the sporozoite demonstrated and were indicating a conformation-dependent microscopy the surface to sporozoites for the and were for to sporozoite invasion of liver cells three conformation-dependent and were to of liver These with by B. P. Hoffman S.L. J.A. F. H. Immunol. PubMed Scopus Google antibodies to a to the C-terminal region of CSP to sporozoite invasion of To of the TSR domain in the recombinant of and PpCSP using and with and with of the in the TSR domain Given that and with native CSP the EcCSP and PpCSP a in the TSR domain with native CSP. of the the recombinant proteins and and and PpCSP with the indicating both and PpCSP a structural and the using of the of to in of that the N-terminal the to the The N-terminal a of is with the the and the Given that from the of the coli is that CSP to coli to a N-terminal of of the from to detergent to the of for the N-terminal and were with the The of the N terminus of be to the of the domain that for an PubMed Scopus Google Scholar, J.A. R.L. PubMed Scopus Google Scholar, A. Nussenzweig H. Nussenzweig V. PubMed Scopus Google Scholar). is by the of native CSP that be a as by to N-terminal and for PpCSP to the of of the three recombinant proteins for the were within for human studies EcCSP and PpCSP were by to and structure. of the from the of both proteins using the indicates that both EcCSP and PpCSP contain little of the protein is composed of and and structure. of both proteins in the little structure. the structural domain on is the TSR has an M. R. A. J. J. PubMed Scopus Google Scholar, H. H. P. Sci. PubMed Scopus Google Scholar). However, for vaccine development is of the or on the structure. of both proteins a the recombinant proteins an of structure Furthermore, we to the a from or or the structure The for both EcCSP and PpCSP structure is from to or is a the resulting in is to have a on structure for recombinant biophysical studies of the EcCSP and PpCSP by and a predominant for both and in as The of for is the of is of an the and Furthermore, EcCSP and PpCSP extended on the by sedimentation and sedimentation velocity the that CSP a highly extended structure. To and to the structural of CSP, we all three recombinant proteins by high resolution that of studies the of using an to both and sedimentation velocity in the of CSP. The and the on a that CSP is an extended and flexible with These the evidence CSP has an structure and with previous studies that the structure of the NANP repeat region of CSP. studies NANP by and C. C. J. J.A. J. Am. Scopus Google by C. L. F. C. H. G. J.A. J. Am. Scopus Google and by A. A. J.A. Google all of demonstrated the a H. M. Sci. PubMed Scopus Google Scholar). by C. C. J.A. J. PubMed Scopus Google that by multiple a structure be sedimentation and the that the NANP repeat region of CSP a an and flexible the of the repeat region to the repeat the TSR domain is an structure. the N-terminal domain and the repeat the repeat region and the TSR domain. These to the of and multiple with a of 1.5 1.5 The the the and is to by the Although can S. J. Jr., R.L. L. Miller L.H. A. PubMed Scopus Google Scholar, R. J. PubMed Scopus Google is for the CSP protein with its and high of structure to be in the ribbon-like forms the and the is for the in both the length and the of CSP the of cells has in vitro PubMed Scopus Google Scholar, C. PubMed Scopus Google and to include both of cells in is formed and of cells by of a A. Med. PubMed Scopus Google Scholar, G. Vanderberg J.P. Nussenzweig R.S. Nussenzweig V. A. PubMed Scopus Google Scholar, M. PubMed Scopus Google Scholar, R. S. P. B. M. R. PubMed Scopus Google Scholar). However, the for the protein within this and is abundance of evidence both the N-terminal domain and C-terminal domain in the invasion of from to liver heparin sulfate on the surface of R. J. PubMed Scopus Google Scholar, S. M. P. R. Corradin G. PubMed Scopus Google Scholar, R. R. P. Kumar S. J. PubMed Scopus Google Scholar, Sacci P. J. PubMed Scopus Google Scholar, A. R. R. P. PubMed Scopus Google Scholar, C. P. B. P. Nussenzweig V. PubMed Scopus Google Scholar). the structure of the protein as an flexible rod-like structure on the of or is of we have from expression PpCSP to and to as by the of an and in These evidence of a highly the evidence CSP as an flexible rod-like protein on the surface of sporozoites. to for the and of for and on B. for with the for sporozoites for and for and protein respectively. with

Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate | Litlas